Technology Hardware, Storage and Peripherals

JOLIMARK

JOLIMARK released FY2025 9 Months earnings on March 30 (BJT), actual revenue HKD 116.03 M, actual EPS HKD -0.0715

JOLIMARK released FY2025 Q3 earnings on March 30, 2026 (BJT), with actual revenue of HKD 40.02 M and EPS of HKD -0.0169

JOLIMARK released FY2025 Annual Earnings on March 30 After-Market (BJT), Actual Revenue: HKD 156.75 M, Actual EPS: HKD -0.0885

JOLIMARK released FY2025 Q4 earnings on March 30 After-Market (BJT), actual revenue HKD 40.71 M, actual EPS HKD -0.0172

JOLIMARK FY2025 Annual Earnings Release on March 30, 2026 After-Market (BJT)

JOLIMARK released FY2025 Q1 earnings on August 27, 2025 (BJT) with actual revenue of HKD 37.59 M and EPS of HKD -0.027

JOLIMARK released FY2025 Semi-Annual earnings on August 27 After-Market (BJT), actual revenue HKD 76 M, actual EPS HKD -0.0546

JOLIMARK released FY2025 Q2 earnings on August 27 After-Market (BJT), actual revenue HKD 38.41 M, actual EPS HKD -0.0276

JOLIMARK to Release FY2025 Semi-Annual Earnings on August 27, 2025 (BJT)

Ming Mee Holdings Annual General Meeting to Discuss Director Re-election and Share Buyback

Yingmei Holdings Releases 2024 Annual Results, Revenue Decreases by 26.41%, Shareholder Loss of 59.834 Million Yuan

JOLIMARK released FY2024 9 Months Earnings on March 28 (BJT), with actual revenue of 127.21 M HKD and EPS of -0.0915 HKD

JOLIMARK released FY2024 Q3 earnings on March 28, 2025 (BJT), with actual revenue of 36.3 M HKD and EPS of -0.0149 HKD

JOLIMARK released FY2024 Q4 earnings on March 28 After-Market (BJT), actual revenue 34.84 M HKD, actual EPS -0.0143 HKD

JOLIMARK released FY2024 annual earnings on March 28 After-Market (BJT), actual revenue 162.09 M HKD, actual EPS -0.106 HKD

JOLIMARK FY2024 Annual Earnings Release Scheduled for March 28, 2025, After-Market BJT

Yingmei Holdings Expects Losses of 57 to 67 Million Yuan for 2024

Emperor Entertainment Group releases full-year 2023 results

Ying Mei Holdings releases announcement on preliminary review of unaudited comprehensive management accounts for the year ended December 31, 2023

CH DEMETER FIN

FAMEGLOW

LUEN THAI

NEW GONOW RV

REF HOLDINGS

PARADISE ENT

WEBX HOLDING

HAICHANG HLDG

BEST FOOD HLDG

INTELLIMARK W27

02028

Jolimark Holdings Limited (HKG:2028) shares have dropped 30% in the past month, despite a 106% gain over the last year. The company's price-to-sales (P/S) ratio is 0.4x, significantly lower than many peers in the Tech industry. Revenue has declined by 20% over the past year and 62% over three years, contrasting with the industry's expected growth of 17%. This poor revenue performance is likely the reason for the low P/S ratio, and unless conditions improve, the share price may remain under pressure. Investors should also consider five warning signs before investing.

Simplywall

The Market Doesn't Like What It Sees From Jolimark Holdings Limited's (HKG:2028) Revenues Yet As Shares Tumble 30%

JOLIMARK announced its interim results for the period ending June this year, with a revenue of RMB 70.195 million, a year-on-year decrease of 16.7%. The loss narrowed to RMB 30.935 million, compared to a loss of RMB 43.406 million in the same period last year; the loss per share is RMB 0.05. No dividend is declared

AASTOCKS

In the first half of the year, JOLIMARK narrowed its loss to 30.935 million RMB and did not declare a dividend

According to the Zhitong Finance APP, JOLIMARK released its interim results for the six months ending June 30, 2025, reporting revenue of 70.195 million yuan, a year-on-year decrease of 16.67%; the loss attributable to shareholders was 30.935 million yuan, a year-on-year decrease of 28.73%; and the loss per share was 0.05 yuan. The announcement stated that the decrease in revenue was mainly due to the continued comprehensive implementation of digital electronic invoices in mainland China and insufficient market demand

Zhitong

JOLIMARK released its interim results, with a loss attributable to shareholders of 30.935 million yuan, a year-on-year decrease of 28.73%

JOLIMARK further updated its profit warning, expecting a loss of between RMB 30 million and RMB 35 million for the six months ending June this year, lower than the estimate originally announced by the board in August, and also lower than the previous estimate mainly due to a decrease in asset impairment provisions. Previously, the company expected a loss of between RMB 35 million and RMB 40 million during the period

"Profit Warning" JOLIMARK latest expects mid-term loss between 30 million to 35 million RMB

According to the announcement from JOLIMARK, following a further review of the unaudited consolidated management accounts of the group for the six months ending June 30, 2025, the group expects to incur a loss of between RMB 30 million and RMB 35 million for the six months ending June 30, 2025, which is lower than the estimate originally announced by the board in August, primarily due to a reduction in the provision for asset impairment

JOLIMARK expects a mid-term loss of 30 million to 35 million yuan

JOLIMARK fell over 30%, as of the time of writing, down 30.49%, priced at HKD 0.155, with a trading volume of HKD 3.6113 million. In terms of news, JOLIMARK was briefly suspended yesterday afternoon and continued to decline after resuming trading this morning. It is worth noting that the stock had surged significantly in the previous two trading days, with a cumulative increase of up to 346%. JOLIMARK announced that compared to a loss of RMB 43.495 million in the same period last year, the group expects to incur a loss of RMB 35 million to 40 million in the first half of 2025. The main reasons for the loss are due to a decline in printer demand, asset impairment provisions, and the lack of large-scale sales of medical products

Understanding the Market | JOLIMARK fell over 30% after surging 3 times in the previous two days, expecting a maximum loss of 40 million yuan in the first half of the year

According to the Zhitong Finance APP, JOLIMARK announced that it expects to incur a loss of RMB 35 million to 40 million in the first half of 2025, compared to a loss of RMB 43.495 million in the same period last year. The main reasons for the loss are the decline in printer demand, asset impairment provisions, and the lack of scale sales for medical products. In addition, the company has applied for its shares to resume trading starting from 9:00 AM on August 13, 2025

JOLIMARK issued a profit warning, expecting a loss of 35 million to 40 million yuan in the first half of the year, and will resume trading on August 13

JOLIMARK temporarily suspended trading on the Hong Kong Stock Exchange, rising 150% before the suspension

JOLIMARK(02028.HK)